Paul H Klingenstein - Net Worth and Insider Trading
Paul H Klingenstein Net Worth
The estimated net worth of Paul H Klingenstein is at least $19 Million dollars as of 2024-06-09. Paul H Klingenstein is the Director of Anacor Pharmaceuticals Inc and owns about 1,809,937 shares of Anacor Pharmaceuticals Inc (ANAC) stock worth over $18 Million. Paul H Klingenstein is also the Director, 10% Owner of Conatus Pharmaceuticals Inc and owns about 2,279,363 shares of Conatus Pharmaceuticals Inc (CNAT) stock worth over $1 Million. Details can be seen in Paul H Klingenstein's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Paul H Klingenstein has not made any transactions after 2013-07-30 and currently still holds the listed stock(s).
Transaction Summary of Paul H Klingenstein
Paul H Klingenstein Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul H Klingenstein owns 5 companies in total, including Clovis Oncology Inc (CLVSQ) , Anacor Pharmaceuticals Inc (ANAC) , and Histogen Inc (HSTO) among others .
Click here to see the complete history of Paul H Klingenstein’s form 4 insider trades.
Insider Ownership Summary of Paul H Klingenstein
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CLVSQ | Clovis Oncology Inc | 2016-06-09 | director |
| ANAC | Anacor Pharmaceuticals Inc | 2014-05-29 | director |
| HSTO | Histogen Inc | 2013-07-24 | director & 10 percent owner |
 | | 2013-05-08 | director |
| | 2004-07-28 | 10 percent owner |
Paul H Klingenstein Latest Holdings Summary
Paul H Klingenstein currently owns a total of 2 stocks. Among these stocks, Paul H Klingenstein owns 1,809,937 shares of Anacor Pharmaceuticals Inc (ANAC) as of November 30, 2010, with a value of $18 Million and a weighting of 93.3%. Paul H Klingenstein also owns 2,279,363 shares of Conatus Pharmaceuticals Inc (CNAT) as of July 30, 2013, with a value of $1 Million and a weighting of 6.7%.
Latest Holdings of Paul H Klingenstein
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ANAC | Anacor Pharmaceuticals Inc | 2010-11-30 | 1,809,937 | 9.82 | 17,773,581 |
| CNAT | Conatus Pharmaceuticals Inc | 2013-07-30 | 2,279,363 | 0.56 | 1,276,443 |
Holding Weightings of Paul H Klingenstein
Paul H Klingenstein Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul H Klingenstein has made a total of 0 transactions in Anacor Pharmaceuticals Inc (ANAC) over the past 5 years. The most-recent trade in Anacor Pharmaceuticals Inc is the acquisition of 300,000 shares on November 30, 2010, which cost Paul H Klingenstein around $2 Million.
According to the SEC Form 4 filings, Paul H Klingenstein has made a total of 0 transactions in Conatus Pharmaceuticals Inc (CNAT) over the past 5 years. The most-recent trade in Conatus Pharmaceuticals Inc is the sale of 566 shares on July 30, 2013, which brought Paul H Klingenstein around $6,226.
Insider Trading History of Paul H Klingenstein
- 1
Paul H Klingenstein Trading Performance
GuruFocus tracks the stock performance after each of Paul H Klingenstein's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul H Klingenstein is 57.8%. GuruFocus also compares Paul H Klingenstein's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul H Klingenstein within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Paul H Klingenstein's insider trading performs compared to the benchmark.
Performance of Paul H Klingenstein
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4 | | | | | |
| Relative Return to S&P 500(%) | -2.55 | | | | | |
Paul H Klingenstein Ownership Network
Paul H Klingenstein Owned Company Details
What does Clovis Oncology Inc do?
Who are the key executives at Clovis Oncology Inc?
Paul H Klingenstein is the director of Clovis Oncology Inc. Other key executives at Clovis Oncology Inc include See Remarks Thomas C. Harding , See Remarks Gillian C Ivers-read , and See remarks Lindsey Rolfe .
Clovis Oncology Inc (CLVSQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Clovis Oncology Inc (CLVSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Clovis Oncology Inc (CLVSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Clovis Oncology Inc (CLVSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Clovis Oncology Inc Insider Transactions
Paul H Klingenstein Mailing Address
Above is the net worth, insider trading, and ownership report for Paul H Klingenstein. You might contact Paul H Klingenstein via mailing address: 428 University Ave, C/o Accel Partners, Palo Alto Ca 94301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
